Acadia Pharmaceuticals | ACAD - Creditori Commerciali





Creditori Commerciali Cambiamento Data
Acadia Pharmaceuticals USD 12.25M 1.34M 2026-03
ALKERMES USD 102.36M 5.59M 2026-03
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Biogen USD 358.5M 73.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Cara Therapeutics USD 3.22M 859K 2025-12
Corcept Therapeutics USD 33.31M 7.14M 2026-03
Cytokinetics USD 24.71M 80.91M 2026-03
Eisai JPY 75.89B 9.6B 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Incyte USD 228.62M 1.41B 2026-03
J&J USD 10.46B 1.53B 2026-03
Moderna USD 161M 156M 2026-03
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Pfizer USD 4.51B 734M 2026-03
Prothena USD 4.3M 1.58M 2026-03
PTC Therapeutics USD 25.48M 20M 2026-03
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Ultragenyx Pharmaceutical USD 42M 11M 2026-03
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03